EFFICACY OF PIRIBEDIL AT DIFFERENT STAGES OF PARKINSON’S DISEASE
- Authors: Troshlna O.1, Esina T.1, Chernyshova A.1
-
Affiliations:
- Voronezh Regional Clinical Hospital One
- Issue: Vol 27, No 3 (2016)
- Pages: 32-34
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116513
- ID: 116513
Cite item
Abstract
Piribedil reduces the degree of major motor symptoms, including the manifestations of motor fluctuations and drug-induced dyskinesia, as well as postural disorders, in Parkinson’s disease.
Full Text
About the authors
O. Troshlna
Voronezh Regional Clinical Hospital One
Email: onaumenko@mail.ru
T. Esina
Voronezh Regional Clinical Hospital One
Email: onaumenko@mail.ru
A. Chernyshova
Voronezh Regional Clinical Hospital One
Email: onaumenko@mail.ru
References
- Диагностика и лечение экстрапирамидных расстройств. Под ред. В.Н. Штока / М., 2000; с. 138.
- Левин О.С., Федорова Н.В. Болезнь Паркинсона. 3-е изд. / М.: МЕДпресс-информ, 2012; 352 с.
- Кадыков А.С., Манвелов Л.С. Тесты и шкалы в неврологии: руководство для врачей / М.: МЕДпресс-информ, 2015; 224 с.
- Федорова Н.В., Чигирь И.П. Болезнь Паркинсона // Лечащий врач. -2005; 6: 34-40.
- Шток В.Н., Федорова Н.В. Лечение паркинсонизма / М., 1997; 194 с.
- Cohen G. Oxygen radicals and Parkinson's disease. Oxygen radicals and tissue injury. Ed. B. Halliwell / Federation of American Societies for Experimental Biology: Bethesda, MD, 1988; 130-5.
- Lang A. Are the new dopamine agonists better than the old ones? 6th International congress of Parkinson's disease and movement disorders Barcelona. Spain, 2000.
- Olanow C., Obeso J. Pulsatile stimulation of dopamine receptors and levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitors // Neurology. - 2000; 55 (4): 72-7.
- Parkers J., Baxter R., Marsden C. et al. Comparative trial benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease // J. Neural. Neurosurg. Psychiatry. - 1974; 37: 422-6.